Label: GOUT RELIEF 3310-S- celery seed, medicago sativa whole,chicory root capsule
- NDC Code(s): 85631-003-01
- Packager: Bispit Canada Ltd.
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved homeopathic
DISCLAIMER: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.
Drug Label Information
Updated August 2, 2025
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
-
ACTIVE INGREDIENT
CELERY SEED 1G1EAA320L 20.00%
MEDICAGO SATIVA WHOLE DJO934BRBD 20.00%
CHICORY ROOT 090CTY533N 18.00%
GLUCOSAMINE HYDROCHLORIDE 750W5330FY 10.00%
BUCKWHEAT N0Y68724R3 7.00%
TEA LEAF GH42T47V24 5.00%
PUERARIN Z9W8997416 5.00%
MORUS ALBA LEAF M8YIA49Q2P 3.00%
LICORICE 61ZBX54883 0.20%
SODIUM CHLORIDE 451W47IQ8X 2.00% - PURPOSE
- KEEP OUT OF REACH OF CHILDREN
- DOSAGE & ADMINISTRATION
- INDICATIONS & USAGE
-
WARNINGS
For your health, please read the followingcarefully
1. The use of three vials can effectivety dissolve crystallization (ittakes time to dissolve crystallization);2. The product has great somatosensation after taking it atleast 21 days in the early stage;3. Elevated uric acid or gout recurrence and site changes arenormal in the early stage of taking this product;4. Try not to drink alcohol or drink less 15 days before takingthis product;
5. This product certainly has significant effect on gout,crystallization and hyperuricemia; - OTHER SAFETY INFORMATION
- INACTIVE INGREDIENT
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
GOUT RELIEF 3310-S
celery seed, medicago sativa whole,chicory root capsuleProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:85631-003 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength GLUCOSAMINE HYDROCHLORIDE (UNII: 750W5330FY) (GLUCOSAMINE - UNII:N08U5BOQ1K) GLUCOSAMINE HYDROCHLORIDE 130 mg in 1.3 g MORUS ALBA LEAF (UNII: M8YIA49Q2P) (MORUS ALBA LEAF - UNII:M8YIA49Q2P) MORUS ALBA LEAF 39 mg in 1.3 g LICORICE (UNII: 61ZBX54883) (LICORICE - UNII:61ZBX54883) LICORICE 2.6 mg in 1.3 g PUERARIN (UNII: Z9W8997416) (PUERARIN - UNII:Z9W8997416) PUERARIN 65 mg in 1.3 g BUCKWHEAT (UNII: N0Y68724R3) (BUCKWHEAT - UNII:N0Y68724R3) BUCKWHEAT 91 mg in 1.3 g SODIUM CHLORIDE (UNII: 451W47IQ8X) (SODIUM CATION - UNII:LYR4M0NH37) SODIUM CHLORIDE 26 mg in 1.3 g MEDICAGO SATIVA WHOLE (UNII: DJO934BRBD) (MEDICAGO SATIVA WHOLE - UNII:DJO934BRBD) MEDICAGO SATIVA WHOLE 260 mg in 1.3 g TEA LEAF (UNII: GH42T47V24) (TEA LEAF - UNII:GH42T47V24) TEA LEAF 65 mg in 1.3 g CELERY SEED (UNII: 1G1EAA320L) (CELERY SEED - UNII:1G1EAA320L) CELERY SEED 260 mg in 1.3 g CHICORY ROOT (UNII: 090CTY533N) (CHICORY ROOT - UNII:090CTY533N) CHICORY ROOT 234 mg in 1.3 g Inactive Ingredients Ingredient Name Strength CELLULOSE GUM (UNII: K679OBS311) CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) MALTOSYL-ISOMALTOTETRAOSE (UNII: B9HR7A9UFR) MAGNESIUM STEARATE (UNII: 70097M6I30) Product Characteristics Color white Score score with uneven pieces Shape CAPSULE Size 20mm Flavor Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:85631-003-01 60 in 1 BOX 07/28/2025 1 1.3 g in 1 CAPSULE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved homeopathic 07/28/2025 Labeler - Bispit Canada Ltd. (243332192) Registrant - Bispit Canada Ltd. (243332192)
